Clinical Trials Browser

Phase 2 × Recruiting × Ras-mutated Metastatic Colorectal Cancer × Clear all

NCT07446322 2026-05-05

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Ras-mutated Metastatic Colorectal Cancer